01 1NINTEDANIB ESYLATE
02 8Nintedanib Esylate
01 15939246.45
02 1198860645.8
03 1371895202.82
04 1494127312.39
05 1618635441.84
06 1789557041.7
07 11157563827.8
08 11495198249.4
09 11762963783.1
01 12014
02 12015
03 12016
04 12017
05 12018
06 12019
07 12020
08 12021
09 12022
Company :
Nintedanib Esylate
Drug Cost (USD) : 1,762,963,783
Year : 2022
Prescribers : 20686
Prescriptions : 143756
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Company :
Nintedanib Esylate
Drug Cost (USD) : 1,495,198,249
Year : 2021
Prescribers : 19476
Prescriptions : 129070
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Company :
Nintedanib Esylate
Drug Cost (USD) : 1,157,563,828
Year : 2020
Prescribers : 15902
Prescriptions : 105327
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Company :
Nintedanib Esylate
Drug Cost (USD) : 789,557,042
Year : 2019
Prescribers : 11971
Prescriptions : 77644
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Company :
Nintedanib Esylate
Drug Cost (USD) : 618,635,442
Year : 2018
Prescribers : 9834
Prescriptions : 66458
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Company :
Nintedanib Esylate
Drug Cost (USD) : 494,127,312
Year : 2017
Prescribers : 8645
Prescriptions : 56153
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Company :
Nintedanib Esylate
Drug Cost (USD) : 371,895,203
Year : 2016
Prescribers : 7231
Prescriptions : 43840
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Company :
Nintedanib Esylate
Drug Cost (USD) : 198,860,646
Year : 2015
Prescribers : 5283
Prescriptions : 24594
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Company :
NINTEDANIB ESYLATE
Drug Cost (USD) : 5,939,246
Year : 2014
Prescribers : 539
Prescriptions : 732
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
LOOKING FOR A SUPPLIER?